KURA ONCOLOGY, INC. (KURA) Free cash flow 2020–2025
KURA ONCOLOGY, INC. (KURA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$70.7MFY2025 · since FY2020: -$72.0M → -$70.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.7M | -152.8% |
| FY2024 | $133.8M | +207.1% |
| FY2023 | -$125.0M | -12.9% |
| FY2022 | -$110.7M | -4.7% |
| FY2021 | -$105.7M | -46.8% |
| FY2020 | -$72.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KURA financial trends
KURA RevenueKURA Net incomeKURA Net marginKURA Gross profitKURA Gross marginKURA Operating incomeKURA Operating marginKURA Operating cash flowKURA Capital expendituresKURA Return on equityKURA Stock buybacksKURA Dividends paidKURA Total assetsKURA Total liabilitiesKURA Shareholders’ equityKURA overview →